Literature DB >> 8093660

Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.

M Kavallaris1, J Madafiglio, M D Norris, M Haber.   

Abstract

Two multidrug-resistant human leukemic CCRF-CEM sublines (CEM/VCR R and CEM/VLB100) were significantly more resistant to tetracycline, a hydrophilic antibiotic, than parental cells (P < 0.001). Verapamil and cyclosporin A completely reversed tetracycline resistance in CEM/VCR R cells, which also accumulated and retained significantly less [3H]tetracycline than CCRF-CEM cells. Like verapamil, addition of tetracycline to CEM/VCR R cells which had achieved steady-state vincristine levels resulted in augmented vincristine accumulation. [3H]Azidopine photoaffinity labelling of CEM/VCR R membrane proteins was inhibited by tetracycline in a dose-dependent manner. Although drugs associated with the multidrug-resistance phenotype are typically hydrophobic compounds, these data suggest that resistance to tetracycline, despite its hydrophilic nature, is mediated by P-glycoprotein in these cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093660     DOI: 10.1006/bbrc.1993.1013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.

Authors:  B T Hill; L K Hosking
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Mycobacterium avium-intracellulare contamination of mammalian cell cultures.

Authors:  I H Lelong-Rebel; Y Piemont; M Fabre; G Rebel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

Review 3.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.

Authors:  Rachel P M Abrams; Adam Yasgar; Tadahisa Teramoto; Myoung-Hwa Lee; Dorjbal Dorjsuren; Richard T Eastman; Nasir Malik; Alexey V Zakharov; Wenxue Li; Muzna Bachani; Kyle Brimacombe; Joseph P Steiner; Matthew D Hall; Anuradha Balasubramanian; Ajit Jadhav; Radhakrishnan Padmanabhan; Anton Simeonov; Avindra Nath
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 12.779

5.  Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells.

Authors:  Claire Levrier; Anja Rockstroh; Brian Gabrielli; Maria Kavallaris; Melanie Lehman; Rohan A Davis; Martin C Sadowski; Colleen C Nelson
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

6.  Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function.

Authors:  Franz Geisslinger; Martin Müller; Yu-Kai Chao; Christian Grimm; Angelika M Vollmar; Karin Bartel
Journal:  Cell Death Dis       Date:  2022-08-01       Impact factor: 9.685

7.  Microscopic Investigation of the Combined Use of Antibiotics and Biosurfactants on Methicillin Resistant Staphylococcus aureus.

Authors:  Abulaziz Juma; Patrick Lemoine; Alistair B J Simpson; Jason Murray; Barry M G O'Hagan; Patrick J Naughton; James G Dooley; Ibrahim M Banat
Journal:  Front Microbiol       Date:  2020-07-07       Impact factor: 5.640

Review 8.  Equine Drug Transporters: A Mini-Review and Veterinary Perspective.

Authors:  Brielle Rosa
Journal:  Pharmaceutics       Date:  2020-11-08       Impact factor: 6.321

Review 9.  ABCB1 in dermatology: roles in skin diseases and their treatment.

Authors:  H J Weng; T F Tsai
Journal:  J Mol Med (Berl)       Date:  2021-08-09       Impact factor: 5.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.